The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-methyl-2-(5-(3-methylmorpholino)-3-(1H-pyrazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7-yl)propanenitrile ID: ALA5193835
Chembl Id: CHEMBL5193835
PubChem CID: 168285807
Max Phase: Preclinical
Molecular Formula: C17H20N8O
Molecular Weight: 352.40
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H]1COCCN1c1nc(C(C)(C)C#N)c2[nH]nc(-c3ccn[nH]3)c2n1
Standard InChI: InChI=1S/C17H20N8O/c1-10-8-26-7-6-25(10)16-20-13-12(11-4-5-19-22-11)23-24-14(13)15(21-16)17(2,3)9-18/h4-5,10H,6-8H2,1-3H3,(H,19,22)(H,23,24)/t10-/m1/s1
Standard InChI Key: GTBPKBHPMAWGEF-SNVBAGLBSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 352.40Molecular Weight (Monoisotopic): 352.1760AlogP: 1.77#Rotatable Bonds: 3Polar Surface Area: 119.40Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.73CX Basic pKa: 1.86CX LogP: 2.18CX LogD: 2.18Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.74Np Likeness Score: -1.25
References 1. Cheng B, Pan W, Xing Y, Xiao Y, Chen J, Xu Z.. (2022) Recent advances in DDR (DNA damage response) inhibitors for cancer therapy., 230 [PMID:35051747 ] [10.1016/j.ejmech.2022.114109 ]